Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease…
Atos Group receives confirmatory offer from the French State to acquire part of its former Advanced Computing business
Press release Atos Group receives confirmatory offer from the French State to…